228 related articles for article (PubMed ID: 20395209)
1. The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression.
Song Y; Aglipay JA; Bernstein JD; Goswami S; Stanley P
Cancer Res; 2010 Apr; 70(8):3361-71. PubMed ID: 20395209
[TBL] [Abstract][Full Text] [Related]
2. The bisecting GlcNAc in cell growth control and tumor progression.
Miwa HE; Song Y; Alvarez R; Cummings RD; Stanley P
Glycoconj J; 2012 Dec; 29(8-9):609-18. PubMed ID: 22476631
[TBL] [Abstract][Full Text] [Related]
3. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
[TBL] [Abstract][Full Text] [Related]
4. Antibodies that recognize bisected complex N-glycans on cell surface glycoproteins can be made in mice lacking N-acetylglucosaminyltransferase III.
Lee J; Park SH; Stanley P
Glycoconj J; 2002 Mar; 19(3):211-9. PubMed ID: 12815232
[TBL] [Abstract][Full Text] [Related]
5. Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression.
Bhaumik M; Harris T; Sundaram S; Johnson L; Guttenplan J; Rogler C; Stanley P
Cancer Res; 1998 Jul; 58(13):2881-7. PubMed ID: 9661906
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of three gain-of-function CHO mutants that add the bisecting GlcNAc to N-glycans.
Stanley P; Sundaram S; Tang J; Shi S
Glycobiology; 2005 Jan; 15(1):43-53. PubMed ID: 15329358
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients.
Kohler RS; Anugraham M; López MN; Xiao C; Schoetzau A; Hettich T; Schlotterbeck G; Fedier A; Jacob F; Heinzelmann-Schwarz V
Oncotarget; 2016 Aug; 7(32):51674-51686. PubMed ID: 27429195
[TBL] [Abstract][Full Text] [Related]
8. Glycoproteomic analysis reveals the effects of bisecting GlcNAc in intrahepatic cholangiocarcinoma.
Dan W; Li C; Li J; Li P; Xin M; Chen Z; Dang L; Yu Z; Li J; Shen J; Hu L; Sun S
Glycoconj J; 2022 Dec; 39(6):737-745. PubMed ID: 36322335
[TBL] [Abstract][Full Text] [Related]
9. Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction.
Priatel JJ; Sarkar M; Schachter H; Marth JD
Glycobiology; 1997 Feb; 7(1):45-56. PubMed ID: 9061364
[TBL] [Abstract][Full Text] [Related]
10. Truncated, inactive N-acetylglucosaminyltransferase III (GlcNAc-TIII) induces neurological and other traits absent in mice that lack GlcNAc-TIII.
Bhattacharyya R; Bhaumik M; Raju TS; Stanley P
J Biol Chem; 2002 Jul; 277(29):26300-9. PubMed ID: 11986323
[TBL] [Abstract][Full Text] [Related]
11. Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III.
Yang X; Tang J; Rogler CE; Stanley P
Cancer Res; 2003 Nov; 63(22):7753-9. PubMed ID: 14633700
[TBL] [Abstract][Full Text] [Related]
12. New evidence for an extra-hepatic role of N-acetylglucosaminyltransferase III in the progression of diethylnitrosamine-induced liver tumors in mice.
Yang X; Bhaumik M; Bhattacharyya R; Gong S; Rogler CE; Stanley P
Cancer Res; 2000 Jun; 60(12):3313-9. PubMed ID: 10866326
[TBL] [Abstract][Full Text] [Related]
13. Large induces functional glycans in an O-mannosylation dependent manner and targets GlcNAc terminals on alpha-dystroglycan.
Hu Y; Li ZF; Wu X; Lu Q
PLoS One; 2011 Feb; 6(2):e16866. PubMed ID: 21347376
[TBL] [Abstract][Full Text] [Related]
14. Bisecting N-Acetylglucosamine on EGFR Inhibits Malignant Phenotype of Breast Cancer via Down-Regulation of EGFR/Erk Signaling.
Cheng L; Cao L; Wu Y; Xie W; Li J; Guan F; Tan Z
Front Oncol; 2020; 10():929. PubMed ID: 32612952
[TBL] [Abstract][Full Text] [Related]
15. Bisecting GlcNAc restricts conformations of branches in model N-glycans with GlcNAc termini.
Hanashima S; Suga A; Yamaguchi Y
Carbohydr Res; 2018 Feb; 456():53-60. PubMed ID: 29274553
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
17. Peptide Sequence Mapping around Bisecting GlcNAc-Bearing
Ohkawa Y; Kizuka Y; Takata M; Nakano M; Ito E; Mishra SK; Akatsuka H; Harada Y; Taniguchi N
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445285
[No Abstract] [Full Text] [Related]
18. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
19. Introduction of bisecting GlcNAc in N-glycans of adenylyl cyclase III enhances its activity.
Li W; Takahashi M; Shibukawa Y; Yokoe S; Gu J; Miyoshi E; Honke K; Ikeda Y; Taniguchi N
Glycobiology; 2007 Jun; 17(6):655-62. PubMed ID: 17324955
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis.
Berger T; Cheung CC; Elia AJ; Mak TW
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2995-3000. PubMed ID: 20133630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
